vs
Idexx Laboratories（IDXX）与MongoDB, Inc.（MDB）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是MongoDB, Inc.的1.7倍（$1.1B vs $628.3M），Idexx Laboratories净利率更高（22.8% vs -0.3%，领先23.1%），MongoDB, Inc.同比增速更快（18.7% vs 14.3%），Idexx Laboratories自由现金流更多（$326.3M vs $141.8M），过去两年MongoDB, Inc.的营收复合增速更高（17.1% vs 6.4%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
MongoDB Inc.是美国软件企业，核心业务为开发面向非结构化数据的数据库引擎MongoDB并提供相关商用技术支持。该产品脱胎于NoSQL数据库，后续新增ACID事务等能力，功能覆盖场景持续拓展，可充分满足全球企业级客户的多元需求。
IDXX vs MDB — 直观对比
营收规模更大
IDXX
是对方的1.7倍
$628.3M
营收增速更快
MDB
高出4.4%
14.3%
净利率更高
IDXX
高出23.1%
-0.3%
自由现金流更多
IDXX
多$184.5M
$141.8M
两年增速更快
MDB
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $628.3M |
| 净利润 | $248.2M | $-2.0M |
| 毛利率 | 60.3% | 71.5% |
| 营业利润率 | 28.9% | -2.9% |
| 净利率 | 22.8% | -0.3% |
| 营收同比 | 14.3% | 18.7% |
| 净利润同比 | 14.8% | 79.5% |
| 每股收益（稀释后） | $3.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXMDB
| Q4 25 | $1.1B | $628.3M | ||
| Q3 25 | $1.1B | $591.4M | ||
| Q2 25 | $1.1B | $549.0M | ||
| Q1 25 | $998.4M | $548.4M | ||
| Q4 24 | $954.3M | $529.4M | ||
| Q3 24 | $975.5M | $478.1M | ||
| Q2 24 | $1.0B | $450.6M | ||
| Q1 24 | $964.1M | $458.0M |
净利润IDXXMDB
| Q4 25 | $248.2M | $-2.0M | ||
| Q3 25 | $274.6M | $-47.0M | ||
| Q2 25 | $294.0M | $-37.6M | ||
| Q1 25 | $242.7M | $15.8M | ||
| Q4 24 | $216.1M | $-9.8M | ||
| Q3 24 | $232.8M | $-54.5M | ||
| Q2 24 | $203.3M | $-80.6M | ||
| Q1 24 | $235.6M | $-55.5M |
毛利率IDXXMDB
| Q4 25 | 60.3% | 71.5% | ||
| Q3 25 | 61.8% | 71.0% | ||
| Q2 25 | 62.6% | 71.2% | ||
| Q1 25 | 62.4% | 72.8% | ||
| Q4 24 | 59.8% | 74.4% | ||
| Q3 24 | 61.1% | 73.2% | ||
| Q2 24 | 61.7% | 72.8% | ||
| Q1 24 | 61.5% | 75.0% |
营业利润率IDXXMDB
| Q4 25 | 28.9% | -2.9% | ||
| Q3 25 | 32.1% | -11.0% | ||
| Q2 25 | 33.6% | -9.8% | ||
| Q1 25 | 31.7% | -3.4% | ||
| Q4 24 | 27.4% | -5.3% | ||
| Q3 24 | 31.2% | -14.9% | ||
| Q2 24 | 26.3% | -21.8% | ||
| Q1 24 | 31.0% | -15.5% |
净利率IDXXMDB
| Q4 25 | 22.8% | -0.3% | ||
| Q3 25 | 24.8% | -8.0% | ||
| Q2 25 | 26.5% | -6.9% | ||
| Q1 25 | 24.3% | 2.9% | ||
| Q4 24 | 22.7% | -1.8% | ||
| Q3 24 | 23.9% | -11.4% | ||
| Q2 24 | 20.3% | -17.9% | ||
| Q1 24 | 24.4% | -12.1% |
每股收益（稀释后）IDXXMDB
| Q4 25 | $3.09 | — | ||
| Q3 25 | $3.40 | — | ||
| Q2 25 | $3.63 | — | ||
| Q1 25 | $2.96 | — | ||
| Q4 24 | $2.62 | — | ||
| Q3 24 | $2.80 | — | ||
| Q2 24 | $2.44 | — | ||
| Q1 24 | $2.81 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $834.1M |
| 总债务越低越好 | $450.0M | — |
| 股东权益账面价值 | $1.6B | $2.9B |
| 总资产 | $3.4B | $3.6B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资IDXXMDB
| Q4 25 | $180.1M | $834.1M | ||
| Q3 25 | $208.2M | $647.1M | ||
| Q2 25 | $164.6M | $657.8M | ||
| Q1 25 | $164.0M | $490.1M | ||
| Q4 24 | $288.3M | $673.1M | ||
| Q3 24 | $308.6M | $1.3B | ||
| Q2 24 | $401.6M | $815.7M | ||
| Q1 24 | $397.4M | $803.0M |
总债务IDXXMDB
| Q4 25 | $450.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDXXMDB
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.6B | $2.9B | ||
| Q2 25 | $1.5B | $3.0B | ||
| Q1 25 | $1.4B | $2.8B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.3B | ||
| Q1 24 | $1.6B | $1.1B |
总资产IDXXMDB
| Q4 25 | $3.4B | $3.6B | ||
| Q3 25 | $3.4B | $3.5B | ||
| Q2 25 | $3.3B | $3.6B | ||
| Q1 25 | $3.2B | $3.4B | ||
| Q4 24 | $3.3B | $3.2B | ||
| Q3 24 | $3.4B | $3.1B | ||
| Q2 24 | $3.4B | $3.0B | ||
| Q1 24 | $3.4B | $2.9B |
负债/权益比IDXXMDB
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $143.5M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $141.8M |
| 自由现金流率自由现金流/营收 | 29.9% | 22.6% |
| 资本支出强度资本支出/营收 | 2.7% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.43× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | $346.3M |
8季度趋势，按日历期对齐
经营现金流IDXXMDB
| Q4 25 | $355.8M | $143.5M | ||
| Q3 25 | $402.3M | $72.1M | ||
| Q2 25 | $185.7M | $109.9M | ||
| Q1 25 | $238.0M | $50.5M | ||
| Q4 24 | $262.0M | $37.4M | ||
| Q3 24 | $220.1M | $-1.4M | ||
| Q2 24 | $248.3M | $63.6M | ||
| Q1 24 | $198.6M | $54.6M |
自由现金流IDXXMDB
| Q4 25 | $326.3M | $141.8M | ||
| Q3 25 | $371.2M | $71.6M | ||
| Q2 25 | $151.6M | $108.3M | ||
| Q1 25 | $207.9M | $24.6M | ||
| Q4 24 | $232.8M | $35.5M | ||
| Q3 24 | $192.0M | $-2.4M | ||
| Q2 24 | $215.0M | $63.1M | ||
| Q1 24 | $168.3M | $51.9M |
自由现金流率IDXXMDB
| Q4 25 | 29.9% | 22.6% | ||
| Q3 25 | 33.6% | 12.1% | ||
| Q2 25 | 13.7% | 19.7% | ||
| Q1 25 | 20.8% | 4.5% | ||
| Q4 24 | 24.4% | 6.7% | ||
| Q3 24 | 19.7% | -0.5% | ||
| Q2 24 | 21.4% | 14.0% | ||
| Q1 24 | 17.5% | 11.3% |
资本支出强度IDXXMDB
| Q4 25 | 2.7% | 0.3% | ||
| Q3 25 | 2.8% | 0.1% | ||
| Q2 25 | 3.1% | 0.3% | ||
| Q1 25 | 3.0% | 4.7% | ||
| Q4 24 | 3.1% | 0.4% | ||
| Q3 24 | 2.9% | 0.2% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | 3.1% | 0.6% |
现金转化率IDXXMDB
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 0.98× | 3.19× | ||
| Q4 24 | 1.21× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
MDB
| Mongo DB Atlas Related | $470.4M | 75% |
| Other Subscription | $138.7M | 22% |
| Services | $19.2M | 3% |
